Researchers make key discovery about human cancer virus protein

May 15, 2018, University of Minnesota
Credit: University of Minnesota

University of Minnesota researchers in the dentistry school-based Institute for Molecular Virology (IMV) have made a key discovery that could have important implications for developing a strategy to stop the spread of a highly infectious virus currently spreading among remote areas of central Australia. Called human T-cell leukemia virus type 1 (HTLV-1), infection rates are reportedly exceeding 40 percent among adults in those communities. HTLV-1, the first human cancer virus discovered, can cause leukemia and lymphoma.

Louis Mansky, Ph.D., director of the IMV and professor in the School of Dentistry and his team have been investigating how HTLV-1 produces that can spread to other cells in the body. In their research published in the Journal of Virology, researchers created mutations in HTLV-1's main structural protein (called Gag) and investigated how these mutants affected the production of HTLV-1 particles. The spread of HTLV-1 from cell to cell requires , which is critical for establishment of infection in the body.

Through their research, Mansky and his team discovered that a key region in the HTLV-1 Gag protein had critical required to produce .

"By creating these mutants, we found important new insights regarding how the structure of the Gag protein is critically important in making new particles," said Mansky, the lead author of the study and Masonic Cancer Center member.

HTLV-1 is transmitted through sexual contact, blood transfusion and from mother to child by breastfeeding. Along with being a carcinogen, the virus can lead to other serious health conditions and cause a chronic progressive disease of the spinal cord. In this study, Mansky's team also found the key virus protein used to produce a HTLV-1 virus particle is assembled in a manner distinct to that of related viruses like HIV.

"HTLV-1 is poorly understood and this is an important step to better understanding how it infects people and spreads," said Mansky. "Further research is needed to understand the molecular nature of how HTLV-1 virus particles are produced from infected host . In doing so, we will be able to better apply this knowledge toward creating strategies to prevent HTLV-1's spread."

Explore further: Mechanisms of persistent infection for the human T-cell leukemia virus

More information: Jessica L. Martin et al. Critical Role of the HTLV-1 Capsid N-Terminal Domain for Gag-Gag Interactions and Virus Particle Assembly, Journal of Virology (2018). DOI: 10.1128/JVI.00333-18

Related Stories

Mechanisms of persistent infection for the human T-cell leukemia virus

June 3, 2016
Joint research between scientists from Kumamoto University, Japan and Imperial College London, UK has revealed the mechanisms of persistent latent infection of the human T-cell leukemia virus type 1 (HTLV-1). This is an important ...

No two kinds of retroviruses look—or act—the same

July 5, 2016
In the most comprehensive study of its kind, researchers in the Institute for Molecular Virology and School of Dentistry at the University of Minnesota report that most types of retroviruses have distinct, non-identical virus ...

Leukemia-causing retrovirus HTLV-1 vaccine a future possibility

April 13, 2018
A study appearing in the in Proceedings of the National Academy of Sciences gives new clues into how cancers like leukemia form from the retrovirus HTLV-1, as well as insights into the possible creation of a vaccine.

Discovery of new strains of the HTLV-4 virus in hunters bitten by gorillas in Gabon

July 13, 2016
Scientists from the Institut Pasteur and the CNRS have identified two new strains of the HTLV-4 virus in two hunters who were bitten by gorillas in Gabon. These findings, published in the journal Clinical Infectious Diseases, ...

Molecular culprit behind virus-mediated chronic inflammation and cancers identified

April 26, 2018
Within cells infected by Kaposi sarcoma herpesvirus (KSHV), the human protein CADM1 interacts with viral proteins to promote chronic inflammation, which plays a major role in the development of cancers caused by KSHV. Richard ...

Mogamulizumab cuts infected cells in HTLV-1 myelopathy

February 8, 2018
(HealthDay)—For patients with human T-lymphotropic virus type 1 (HTLV-1)-associated myelopathy-tropical spastic paraparesis (HAM-TSP), treatment with the humanized anti-CCR4 monoclonal antibody that targets infected cells, ...

Recommended for you

Deadly Rift Valley fever: New insight, and hope for the future

July 19, 2018
Health control measures alone could be ineffective in the long term fight against the deadly Rift Valley fever which affects both humans and animals, a new study in the journal PNAS reports.

New guidelines to diagnose, manage rare endocrine disorders

July 19, 2018
International guidelines have been published for the first time to help doctors around the globe diagnose and manage patients with a very rare set of endocrine diseases known as pseudohypoparathyroidism and its related disorders, ...

Overuse of antibiotics not what the doctor ordered

July 19, 2018
With increased use of antibiotics worldwide linked to growing antibiotic resistance, a world-first study co-authored by a QUT researcher has highlighted the growing impact of non-prescription supply of antibiotics in community ...

Alcohol-related cirrhosis deaths skyrocket in young adults

July 18, 2018
Deaths from cirrhosis rose in all but one state between 1999-2016, with increases seen most often among young adults, a new study shows.

Hidden blood in feces may signal deadly conditions

July 17, 2018
(HealthDay)—Even if it's not visible to the naked eye, blood in the stool can be serious—a sign of a potentially fatal disease other than colon cancer, new research suggests.

Childhood abuse linked to greater risk of endometriosis, study finds

July 17, 2018
Endometriosis, a painful condition that affects one in 10 reproductive-age women in the U.S., has been linked to childhood physical and sexual abuse, according to findings published today in the journal Human Reproduction.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.